Launch of topical pain cream and wholesale website accompany name change for CBD products maker.
US Lithium Corp., soon to be renamed BioELife, this month has launched its beta ecommerce website, www.bioelife.net, and began shipping its newest product, a highly concentrated topical 2,000 mg CBD intensive pain cream called ChiroRub 2000.
The new site will allow wholesale customers as well as consumers to register, view and purchase all of BioELife’s current product offerings, which include adult CBD gum drops as well as the company’s premium pre-rolls and flower from its farm partner, Hemp Heaven Farms.
“BioELife.net offers wholesalers a convenient method to view our expanding product line and order products for distribution,” said Gregory Rotelli, US Lithium board chairman and president. “We are excited that Hemp Heaven Farms is now supplying premium flower from last year’s harvest and is available in bulk or manufactured pre-roll form. Our pre-roll conforms to various state regulations, including Texas, which prohibits the manufacture of pre-rolls within its borders.”
The company’s corporate site, www.bioelife.com, will provide corporate background, investor relations, and information on current and upcoming products. It is expected to be launched later this month.
The name change to BioELife is meant to reflect the company’s shift of focus to the CDB marketplace and product development.
CBD Pain Relief Cream
The company said that its ChiroRub 2000 has been doctor and patient tested and is one of the most effective pain relief creams currently available today. The CBD pain cream was developed in conjunction with leading physicians, chiropractors and medical professionals who evaluated and validated the product’s efficacy throughout several developmental phases.
“It is one step toward our goal of improving people’s lives through the use of non-addictive remedies that provide relief and are cost effective,” said Rotelli. “This further reflects our continuing commitment to product development in conjunction with our medical professional advisors and customers.”
The company partners with well-known farmers, certified contract manufacturers and key distributors to produce and distribute products at the lowest possible cost. Several of its products, the company said, are being marketed by medical networks in various combination packages to maximize patient benefits and efficacy.
US Lithium Corp’s new strategic direction as BioELife was created by successful pharmaceutical entrepreneurs dedicated to using natural resources to fight pain and infection while reducing the dependency on opioids and their side effects. The company said it is uniquely positioned to capitalize on the emerging cannabinoid market that is growing at phenomenal rates and is expected to reach $20 billion over the next five years.
The name change should be completed within the next thirty days, the company said.